Abstract Library

#1699 Should the Selective Arterial Secretagogue Injection Test for Insulinoma Localization be Evaluated at 60 Seconds or At 120 Seconds?

Introduction: The selective arterial secretagogue injection (SASI) test is considered indispensable for an accurate insulinoma localization. The optimal timing of post-injection evaluation has not been established yet, as some studies recommend 60 seconds [SASI (60 sec)] while others support 120 seconds [SASI (120 sec)].

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Ueda K, Kawabe K, Lee L, Tachibana Y, Fujiyama T,

Keywords: insulinoma, selective arterial secretagogue injection test, localization, insulin,

#1264 Efficacy and Safety of Sunitinib as Long-term Treatment in Japanese Patients with Advanced Pancreatic Neuroendocrine Tumors.

Introduction: The results from recent clinical trials have suggested the ethnical difference in antitumor activity of sunitinib against advanced pancreatic neuroendocrine tumors (PNET), which seemed to be higher in Japanese than those in Western patients.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Lee L

Authors: Lee L, Ueda K, Fujiyama T, Tachibana Y, Yasunaga K,

Keywords: sunitinib, pancreatic neuroendocrine tumor,

#814 Chromogranin A is a Useful Marker in Japanese Patients with Pancreatic Neuroendocrine Tumors

Introduction: Although Chromogranin A (CgA) is known as a useful marker for pancreatic neuroendocrine tumors (pNET) in the West, the usefulness of CgA in Japanese patients with pNETs is unclear.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Hijioka M, Ito T, Igarashi H, Ueda K, Fujiyama T,

Keywords: chromogranin A, pNET, Japanese,